FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry. Disclosed is cDNA of natural GDNF gene artificially modified by removal of pro-region, which in mammalian cells or tissues in standard vectors produces active specific GDNF. Invention also relates to an expression vector containing said cDNA, as well as to active specific GDNF encoded by said cDNA. During translation in cells and tissues said GDNF stimulates neural differentiation of stem and progenitor cells with formation of neural processes.
EFFECT: invention increases activity of GDNF as neural inductor and stimulator of formation of neural processes and can be used in therapy of neurodegenerative disorders, traumatic disorders of innervation as well as ischemic cerebral apoplexies of mammals, including humans.
3 cl, 13 dwg, 5 ex
Title | Year | Author | Number |
---|---|---|---|
GENETIC CONSTRUCT CONTAINING hGDNF CONTROLLED BY TEMPERATURE-SENSITIVE PROMOTOR FOR REGULATED NEUROTROPHIC FACTOR EXPRESSION IN MAMMALIAN CELLS AND BODIES DIRECTLY | 2012 |
|
RU2527169C2 |
IMPROVED METHOD FOR DIFFERENTIATION OF INDUCED PLURIPOTENT HUMAN STEM CELLS INTO DOPAMINERGIC NEURONS | 2023 |
|
RU2823290C1 |
METHOD OF PRODUCING MAMMAL EMBRYONIC STEM CELLS MODIFIED WITH HUMAN NERVE GROWTH FACTOR GENE | 2011 |
|
RU2458984C1 |
METHOD OF OBTAINING POPULATION OF NEURAL DIFFERENTIATION INDUCED STROMAL CELLS OF FAT TISSUE | 2008 |
|
RU2396345C1 |
METHOD FOR STIMULATING SPINAL CORD REGENERATION WITH GENETICALLY MODIFIED HUMAN UMBILICAL CORD BLOOD CELLS | 2013 |
|
RU2521225C2 |
GENETIC ENGINEERING STRUCTURE FOR STIMULATING POST-TRAUMATIC REGENERATION OF PERIPHERAL NERVES | 2019 |
|
RU2719013C1 |
METHOD OF PRODUCING GLIAL DERIVATIVES OF INDUCED PLURIPOTENT STEM CELLS WITH INCREASED EXPRESSION OF NGF FOR THERAPY OF NEURODEGENERATIVE DISEASES | 2023 |
|
RU2829363C1 |
METHOD OF PRODUCING GLIAL DERIVATIVES OF INDUCED PLURIPOTENT STEM CELLS WITH INCREASED EXPRESSION OF BDNF FOR THERAPY OF ISCHEMIC STROKE | 2023 |
|
RU2829361C1 |
2-((1H-1,2,4-TRIAZO-3-YL)THIO)-3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-3-EN-1-OL AS AN ANTIPARKINSONIAN AGENT | 2022 |
|
RU2796729C1 |
PRODUCTION OF TERMINAL-DIFFERENTIATED DOFAMINNERGIC NEURONES FROM EMBRIONIC HUMAN FOUNDER CELLS | 2004 |
|
RU2345133C2 |
Authors
Dates
2016-08-27—Published
2014-10-24—Filed